Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
The molecule also includes modifications that extend its half-life to about 5 days, enabling once-weekly dosing
Verhage M, Maia AS, Plomp JJ, Brussaard AB, Joost H, Vermeer H, et al
Your prescriber can confirm the acceptable rounding range for your protocol
Rinse thoroughly with hot water, then cool your skin with cold water to seal all pores
